INT26507
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
In the rabbit vas deferens preparations (RVD), on the other hand, U-50488H, KK-3 and KK-4 showed weak inhibitory effects and the inhibition of U-50488H and KK-3 were antagonized by norbinaltorphimine. | |||||||||||||||
| |||||||||||||||
|
The stronger suppression of uAUGs with respect to uORFs can be partially explained by the fact that initiation at the main ORF may occur only by leaky scanning in uAUG-containing transcripts, whereas both leaky scanning and ribosome reinitiation may allow initiation at the AUG of main uORF-containing transcripts (53). | |||||||||||||||
| |||||||||||||||
|
Carbachol caused a robust decrease in uIPSC amplitudes in all three types of cell pairs. | |||||||||||||||
| |||||||||||||||
|
M2-type muscarinic receptors were responsible for the reduction in uIPSC amplitudes in FSBC and AACpyramidal cell pairs, while an antagonist of CB1 cannabinoid receptors recovered the suppression in RSBCpyramidal cell pairs. | |||||||||||||||
| |||||||||||||||
|
In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions. | |||||||||||||||
| |||||||||||||||
|
To investigate the role of phospholipase C (PLC) in inflammatory processes, we tested 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), a widely used PLC inhibitor, in several in vitro and in vivo assays. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.